CONNECT WITH US
Tech

Tech

This Man’s Heart Kept Failing for 11 Years. He Was Secretly Taking a Drug Made for Cattle

Gizmodo - Tech logo

Published on

Add as a preferred source on Google
This Man’s Heart Kept Failing for 11 Years. He Was Secretly Taking a Drug Made for Cattle

It was a medical mystery. For 11 years, a middle-aged man who described himself as a workout “fanatic,” according to one doctor who treated him, had suffered from bouts of fatigue, insomnia, kidney trouble, and most concerningly repeated heart failures. These ailments had recurred, for no discernible reason, ever since he’d come back from a trip to the Caribbean at the age of 39.

But things reached a breaking point after another ill-fated Caribbean vacation at age 50, when he returned to the U.S. in the throes of serious heart failure, with the left chamber of his heart pumping out less than half the blood it should per beat, for the second time recorded in his life. Within the first day of his hospitalization, after reporting (among other symptoms) increasing tightness in his chest and fluid building up in his legs, this Massachusetts resident finally admitted a secret that he’d been keeping from his doctors for over a decade: He’d been taking high doses of anabolic-androgenic steroids (AAS) routinely for years—including, most recently, trenbolone, a synthetic hormone used to bulk up beef cattle.

“Use of AAS has now become a major international substance use disorder,” according to Harvard Medical School psychiatrist Harrison Pope, one of the half a dozen medical professionals who submitted the results of this long, perplexing case to the New England Journal of Medicine.

S. men with HIV infection,” Pope wrote in the case study, which he hopes will help other doctors spot the warning signs of illicit steroid use in their own patients.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.